rs7671167

This is a intron variant variant in the FAM13A gene.

GWAS Catalog Trait Associations (3)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

pulmonary surfactant-associated protein d measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.10
p 1.0e-12
N 10,708
Large GWAS
European

BMI-adjusted waist-hip ratio

Allele C
OR 0.02
p 3.0e-9
N 219,872
Major Consortium StudyLarge GWAS
European

ClinVar annotation

Association☆☆☆
2 submitters

Chronic obstructive pulmonary disease

View on ClinVar →

Research that mentions this SNP (1)

Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility
AssociationN=5,296Mateusz Siedlinski et al.(2013)· Human Genetics

This mediation analysis study of 3,424 COPD cases and 1,872 controls examined direct and indirect genetic effects of known COPD susceptibility loci. The AGPHD1/CHRNA3 variants (rs1051730, rs8034191) showed ~30% of their total effect on COPD mediated by pack-years smoking (OR 1.256-1.305), while IREB2 (rs13180) showed no significant smoking-mediated effect, suggesting independent pathways. FAM13A (rs7671167) and HHIP (rs13118928) demonstrated direct effects on COPD independent of smoking.

Traits studied:Chronic obstructive pulmonary disease (COPD)Number of cigarettes per dayPack-years smokedSmoking intensity

About FAM13A

Predicted to enable GTPase activator activity. Predicted to be involved in regulation of small GTPase mediated signal transduction. Predicted to be located in cytosol. Implicated in chronic obstructive pulmonary disease. [provided by Alliance of Genome Resources, Jul 2025]

View all FAM13A variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…